Dr. Seward Brian Rutkove, MD

Dr. Rutkove practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Rutkove's NPI, 1467493809, was assigned on June 9, 2006. Dr. Rutkove graduated from Columbia University College of Physicians and Surgeons in 1989. Dr. Rutkove holds Massachusetts license 80517.

Dr. Rutkove's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Rutkove's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Rutkove is also affiliated with Beth Israel Deaconess Hospital-Plymouth. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Rutkove to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rutkove practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rutkove's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rutkove is licensed in Massachusetts.

CMS data shows 85 Medicare services from Dr. Rutkove across 2 procedure codes in 2024, for 48 Medicare patients. Medicare paid $3,056 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Rutkove in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rutkove's median patient age at 70, with 54% women.

In 2024, Dr. Rutkove wrote 183 Medicare Part D claims for 25 patients. 58% of them were for generic drugs. CMS names the drug for 98 of them, across 5 drugs with 11 or more claims each, at $731,791 in total drug cost. In 2023, CMS named 179 claims across 10 drugs.

Dr. Rutkove accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rutkove as offering telehealth.

Dmand AI links 201 papers to Dr. Rutkove, published from 2004 to 2025. 2019 was the busiest year, with 20. The most frequent topics are Electric Impedance, Muscle, Skeletal and Myography. Dr. Rutkove has published most often in Muscle Nerve. Dr. Rutkove's most frequent co-authors are Basil T. Darras, MD, Jeremy M. Shefner, MD and Courtney E. McIlduff, MD.

Dmand AI links Dr. Rutkove to 3 clinical trials. Conditions studied include Accidental Injuries, Amyotrophic Lateral Sclerosis and Myasthenia Gravis. Beth Israel Deaconess Medical Center sponsors the most, 2.

CMS Open Payments shows 15 general payments to Dr. Rutkove from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $10,103. It also lists 3 research payments totaling $18,000 from 2016 to 2019.

Dr. Rutkove graduated from Columbia University College of Physicians and Surgeons in 1989.